| Risk Factors
Malignant hyperthermia is a dangerous, rapid rise in body temperature due to internal issues. It is most often caused by certain medications, especially anesthesia medication.
People can have a tendency to have malignant hyperthermia which is known as malignant hyperthermia susceptibility.
Malignant hyperthermia susceptibility is often caused by a specific gene mutation. Only 1 parent has to have the defective gene for the child to inherit the susceptibility.
A malignant hyperthermia event is caused by abnormal levels of calcium in the muscle. The change in calcium causes an increase in metabolism. Heat is a side-effect of metabolism.
Copyright © Nucleus Medical Media, Inc.
The abnormal levels of calcium often are triggered by medications used for anesthesia such as:
- Certain inhaled anesthesia gases
- Certain muscle relaxants
Malignant hyperthermia occurs most often in children and people who are Caucasian or of Northern European descent.
The main risk factor is having a family history of malignant hyperthermia.
Symptoms may begin after medication is given and include:
- Fever - often more than 40.6°C (105°F)
- Stiff muscles
- Muscle spasms, especially the facial muscles
- Fast breathing
- Fast or irregular heartbeat
- Dark urine
- An uneven skin color
Malignant hyperthermia is an emergency. It is often suspected based on symptoms and recent anesthesia administration.
Malignant hyperthermia susceptibility may be suspected based on your medical and family history. If you have a positive family history, then your doctor may test you for the susceptibility with:
- Genetic testing
- Muscle biopsy—a sample of muscle tissue is taken and and examined under a microscope
If your condition was triggered by a certain anesthetic, it will be stopped and/or changed.
Emergency care will be given and may include:
- Ending surgery
- Cooled IV fluids and blankets to reduce your temperature
- Oxygen therapy to reduce damage caused by high temperature
- Medications to slow muscle metabolism, control breathing and heart rate.
Kidney and heart tests may also be done to look for any potential complications from the hyperthermia event.
Make sure all of your doctors are aware of your susceptibility to malignant hyperthermia or any family history of malignant hyperthermia.
- Discuss these facts before any surgery or medical procedure. This will allow your doctor to select medications that are less likely to trigger malignant hyperthermia.
- Wear a medical alert bracelet to let emergency responders know about your condition. The bracelet will speak for you if you are unable to do so.
If you think there may be malignant hyperthermia susceptibility in your family, talk to your doctor about genetic testing as part of your family planning process.
American Association of Neuromuscular and Electrodiagnostic Medicine
FAQs: General MH questions. Malignant Hyperthermia Association of the United States website. Available at: http://www.mhaus.org/faqs/about-mh. Accessed September 3, 2015.
Malignant hyperthermia. American Association of Neuromuscular and Electrodiagnostic Medicine website. Available at: http://aanem.org/Patients/Disorders/Malignant-Hyperthermia. Accessed September 3, 2015.
Malignant hyperthermia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T115406/Malignant-hyperthermia. Updated March 4, 2016. Accessed October 3, 2016.
Malignant hyperthermia FAQ. Wake Forest Baptist Health website. Available at: http://www.wakehealth.edu/Anesthesiology/Malignant-Hyperthermia/Malignant-Hyperthermia-FAQ.htm#who%20gets. Updated April 15, 2015. Accessed September 3, 2015.
Malignant hyperthermia. Patient website. Available at: http://patient.info/doctor/malignant-hyperthermia. Updated October 15, 2014. Accessed September 3, 2015.
New and generic drug approvals. Food and Drug Administration website. Available at: http://www.fda.gov/drugs/newsevents/ucm130961.htm. Updated September 3, 2015. Accessed September 3, 2015.
Testing for MH. Malignant Hyperthermia Association of the United States website. Available at: http://www.mhaus.org/testing. Accessed September 3, 2015.
Last reviewed September 2016 by Michael Woods, MD, FAAP
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.